Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dexian Zheng

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|December 1, 2005
Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in miceHong Ma, Yanxin Liu, Shilian Liu, et al.
European Journal of Mass Spectrometry (Chichester, England)|December 3, 2005
An analysis of protein abundance suppression in data dependent liquid chromatography and tandem mass spectrometry with tryptic peptide mixtures of five known proteinsWei Sun, Shuzhen Wu, Xiaorong Wang, et al.
IUBMB Life|May 28, 2009
Tax1 enhances cancer cell proliferation via Ras-Raf-MEK-ERK signaling pathwayChunjiao Song, Weimin Wang, Meng Li, et al.
Genomics, Proteomics & Bioinformatics|May 3, 2005
A systematical analysis of tryptic peptide identification with reverse phase liquid chromatography and electrospray ion trap mass spectrometryWei Sun, Shuzhen Wu, Xiaorong Wang, et al.
Oncology Reports|December 22, 2007
Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cellsMinmin Sun, Jinchun Zhang, Shilian Liu, et al.
Plos One|April 13, 2011
HIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen speciesDan-Ming Zhu, Juan Shi, Shilian Liu, et al.
Current Molecular Medicine|December 20, 2003
TRAIL: a potential agent for cancer therapyJuan Shi, Dexian Zheng, Kwan Man, et al.
Molecular Therapy Oncolytics|June 18, 2021
Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapyShuyong Zhang, Dongdong Zhou, Chao Zheng, et al.
Cell Research|May 13, 2009
TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent mannerWanhu Tang, Weimin Wang, Yaxi Zhang, et al.
Journal of Cellular Biochemistry|August 23, 2005
PKCdelta protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosisJindan Zhang, Ning Liu, Jingchun Zhang, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|December 1, 2005
Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in miceHong Ma, Yanxin Liu, Shilian Liu, et al.
European Journal of Mass Spectrometry (Chichester, England)|December 3, 2005
An analysis of protein abundance suppression in data dependent liquid chromatography and tandem mass spectrometry with tryptic peptide mixtures of five known proteinsWei Sun, Shuzhen Wu, Xiaorong Wang, et al.
IUBMB Life|May 28, 2009
Tax1 enhances cancer cell proliferation via Ras-Raf-MEK-ERK signaling pathwayChunjiao Song, Weimin Wang, Meng Li, et al.
Genomics, Proteomics & Bioinformatics|May 3, 2005
A systematical analysis of tryptic peptide identification with reverse phase liquid chromatography and electrospray ion trap mass spectrometryWei Sun, Shuzhen Wu, Xiaorong Wang, et al.
Oncology Reports|December 22, 2007
Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cellsMinmin Sun, Jinchun Zhang, Shilian Liu, et al.
Plos One|April 13, 2011
HIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen speciesDan-Ming Zhu, Juan Shi, Shilian Liu, et al.
Current Molecular Medicine|December 20, 2003
TRAIL: a potential agent for cancer therapyJuan Shi, Dexian Zheng, Kwan Man, et al.
Molecular Therapy Oncolytics|June 18, 2021
Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapyShuyong Zhang, Dongdong Zhou, Chao Zheng, et al.
Cell Research|May 13, 2009
TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent mannerWanhu Tang, Weimin Wang, Yaxi Zhang, et al.
Journal of Cellular Biochemistry|August 23, 2005
PKCdelta protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosisJindan Zhang, Ning Liu, Jingchun Zhang, et al.
Pageof 7